Statistics
Publications
27
Citations
2.2K
H-Index
19
Active since
1973
Affiliations
Peter D. Davis is an author at Roche (United Kingdom) specializing in pharmacology, medicinal chemistry, and enzyme inhibition.
Publications per year
1973–2020
27
27
Potent selective inhibitors of protein kinase C
Peter D. Davis, Christopher H. Hill, Elizabeth Keech et al. · FEBS Letters · 1989 · 478 citations · Full text
ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.
Peter D. Davis, Graeme J. Dougherty, David C. Blakey et al. · PubMed · 2002 · 231 citations
Medicine, Oncology, Pharmacology +17
Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models.
David C. Blakey, F. Russell Westwood, Mike Walker et al. · PubMed · 2002 · 176 citations
Medicine, Oncology, Pharmacology +16
Inhibitors of protein kinase C. 1. 2,3-bisarylmaleimides
Peter D. Davis, Christopher H. Hill, Geoffrey Lawton et al. · Journal of Medicinal Chemistry · 1992 · 161 citations · Full text
Pharmacy, Chemistry, Pharmacology +12
1–5 of 27